Literature DB >> 27709361

Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma.

Shutaro Hori1,2,3,4, Kazuaki Shimada3, Yoshinori Ino1, Seiji Oguro1,2,3, Minoru Esaki3, Satoshi Nara3, Yoji Kishi3, Tomoo Kosuge3, Yukinori Hattori2, Aoi Sukeda2, Yuko Kitagawa4, Yae Kanai1, Nobuyoshi Hiraoka5,6.   

Abstract

As macroscopic appearance represents tumor microenvironment, it may also reflect the biological and clinicopathological characteristics of a cancer. The aim of the study was to evaluate the clinicopathological significance of the gross appearance of pancreatic ductal adenocarcinoma (PDA). We investigated fresh macroscopic features in 352 cases of PDA and their clinicopathological significance. Three unique gross features were found: a honeycomb-like appearance (diffusely distributed microcysts and interstitial fibrotic thickening), macroscopic necrosis, and a tube/branching structure (apparent small cylindrical or linear structure). A honeycomb-like appearance was present in 24 cases (6.8 %) and significantly associated with low serum CA19-9 level and well-differentiated adenocarcinoma. Macroscopic necrosis was present in 235 cases (66.8 %) and significantly correlated with tumor size, nodal metastasis, nerve plexus invasion, no adjuvant chemotherapy, and distant recurrence. The presence of macroscopic necrosis was significantly associated with shorter disease-specific survival (DSS) and disease-free survival (DFS). The presence of larger areas of necrosis (≥2 mm) was closely associated with shorter survival. A tube/branching structure was found in 179 cases (50.9 %), which was correlated with larger tumor size and no adjuvant chemotherapy and macroscopic necrosis. The presence of a tube/branching structure was significantly associated with shorter DSS and DFS. Multivariate survival analyses showed that the presence of tube/branching structures was an independent negative prognostic factor in patients having PDA. We suggest that the gross appearance of PDA reflects clinicopathological characteristics and may be useful in predicting prognosis.

Entities:  

Keywords:  A honeycomb-like appearance; A tube/branching structure; Macroscopic features; Macroscopic necrosis; Pancreatic ductal adenocarcinoma; Prognosis

Mesh:

Year:  2016        PMID: 27709361     DOI: 10.1007/s00428-016-2026-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.

Authors:  S Eguchi; T Kanematsu; S Arii; M Omata; M Kudo; M Sakamoto; K Takayasu; M Makuuchi; Y Matsuyama; M Monden
Journal:  Br J Surg       Date:  2011-01-25       Impact factor: 6.939

3.  Angiographic evaluation of pancreatic carcinoma.

Authors:  J J Bookstein; S R Reuter; W Martel
Journal:  Radiology       Date:  1969-10       Impact factor: 11.105

4.  Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients.

Authors:  N Fukushima; M Sakamoto; K Mukai; Y Kanai; K Shimada; T Kosuge; S Hirohashi
Journal:  Hum Pathol       Date:  2001-08       Impact factor: 3.466

Review 5.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

6.  Progress in the study of pancreatic cancer and its pathology.

Authors:  A Yanagisawa
Journal:  Semin Surg Oncol       Date:  1998 Jul-Aug

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.

Authors:  Y Ino; R Yamazaki-Itoh; K Shimada; M Iwasaki; T Kosuge; Y Kanai; N Hiraoka
Journal:  Br J Cancer       Date:  2013-02-05       Impact factor: 7.640

9.  Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.

Authors:  Yoshinori Ino; Rie Yamazaki-Itoh; Seiji Oguro; Kazuaki Shimada; Tomoo Kosuge; Jan Zavada; Yae Kanai; Nobuyoshi Hiraoka
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Hidenori Ojima
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

View more
  6 in total

Review 1.  Pancreas ductal adenocarcinoma with cystic features on cross-sectional imaging: radiologic-pathologic correlation.

Authors:  Seo Yeon Youn; Sung Eun Rha; Eun Sun Jung; In Seok Lee
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

2.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma.

Authors:  Jiahao Gao; Fang Han; Yingying Jin; Xiaoshuang Wang; Jiawen Zhang
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

3.  Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies.

Authors:  Gianluca Tomasello; Michele Ghidini; Antonio Costanzo; Antonio Ghidini; Alessandro Russo; Sandro Barni; Rodolfo Passalacqua; Fausto Petrelli
Journal:  J Gastrointest Oncol       Date:  2019-04

4.  Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.

Authors:  Toshimitsu Iwasaki; Nobuyoshi Hiraoka; Yoshinori Ino; Kosei Nakajima; Yoji Kishi; Satoshi Nara; Minoru Esaki; Kazuaki Shimada; Hitoshi Katai
Journal:  Cancer Sci       Date:  2019-03-19       Impact factor: 6.716

5.  Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer.

Authors:  Shengnan Li; Gengpu Zhang; Yang Lu; Tiansuo Zhao; Chuntao Gao; Weishuai Liu; Yongjun Piao; Yanan Chen; Chongbiao Huang; Antao Chang; Jihui Hao
Journal:  Front Oncol       Date:  2022-02-21       Impact factor: 6.244

6.  Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Xiaojie Li; Shengnan Li; Lili Liu; Jiahui Hong; Tiansuo Zhao; Chuntao Gao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.